Verrica Pharmaceuticals  logo
Verrica Pharmaceuticals VRCA
$ 0.89 -7.44%

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Verrica Pharmaceuticals Income Statement 2011-2024 | VRCA

Annual Income Statement Verrica Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

245 M 252 M 227 M 294 M 363 M 176 M - - - - - - -

Shares

45.3 M 34.2 M 27 M 25 M 24.9 M 14.7 M - - - - - - -

Historical Prices

5.41 7.39 8.38 13.7 11.9 11.3 - - - - - - -

Net Income

-67 M -24.5 M -35.1 M -42.7 M -28.2 M -20.6 M -4.46 M -1.91 M - - - - -

Revenue

5.12 M 9.03 M 12 M - - - - - - - - - -

Cost of Revenue

500 K - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - -

Operating Income

-65.8 M -21.3 M -30.9 M -40.2 M -30.1 M -21.9 M -4.46 M - - - - - -

Interest Expense

3.96 M 2.17 M 4.3 M 3.03 M - - - - - - - - -

EBITDA

-65.2 M -20.8 M -30.7 M -40 M -29.8 M -21.9 M -4.46 M -1.91 M - - - - -

Operating Expenses

70.9 M 30.3 M 42.9 M 40.2 M 30.1 M 21.9 M - - - - - - -

General and Administrative Expenses

47.3 M 17.4 M 27 M 24.5 M 14.6 M 9.05 M 727 K 204 K - - - - -

All numbers in USD currency

Quarterly Income Statement Verrica Pharmaceuticals

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

46.5 M 46.5 M 42.4 M 46.1 M 45.9 M 43 M 41.1 M 40.3 M 27.5 M 27.5 M 27.5 M 27.5 M 27.5 M 25.6 M 25.4 M 25 M 25 M 25 M 24.9 M 24.9 M 24.9 M 24.9 M 24.8 M 24.8 M 5.75 M 2.85 M 2.85 M 2.85 M 2.85 M 2.85 M - - - - - - - - - - - - - - - - - - - - - - - -

Net Income

-17.2 M -20.3 M - -24.8 M -11 M -6.59 M - 83 K -10.2 M -8.47 M - -12.8 M -11.8 M -936 K - -10.5 M -9.41 M -9.82 M -7.64 M -6.09 M -7 M -7.48 M -7.58 M -5.91 M -5.32 M -1.85 M -1.44 M -1.36 M -1.1 M -570 K - - - - - - - - - - - - - - - - - - - - - - - -

Revenue

5.18 M 3.83 M - 2.92 M 182 K 37 K - 8.32 M 214 K 431 K - - - 12 M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cost of Revenue

700 K 700 K - 300 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-15.2 M -18.6 M - -23.9 M -11.6 M -7.09 M - 1.45 M -9.12 M -7.41 M - -11.8 M -10.7 M 60 K - -9.64 M -8.63 M -9.88 M -7.99 M -6.54 M -7.52 M -8.03 M -8.19 M -6.33 M -5.47 M -1.89 M -1.43 M -1.36 M -1.1 M -570 K - - - - - - - - - - - - - - - - - - - - - - - -

Interest Expense

2.37 M 2.32 M - 1.66 M - - - 81 K 1.07 M 1.08 M - 1.09 M 1.08 M 1.03 M - 918 K 904 K 220 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA

-15.1 M -18.5 M - - -11.5 M -6.96 M - 1.77 M -8.92 M -7.31 M - -11.7 M -10.7 M 71 K - -9.61 M -8.6 M -9.87 M -7.99 M -6.5 M -7.5 M -8.02 M -8.19 M -6.32 M -5.46 M -1.89 M -1.43 M -1.36 M -1.1 M -570 K - - - - - - - - - - - - - - - - - - - - - - - -

Operating Expenses

20.4 M 22.4 M - 26.8 M 11.8 M 7.13 M - 6.87 M 9.34 M 7.84 M - 11.8 M 10.7 M 11.9 M - 9.64 M 8.63 M 9.88 M 7.99 M 6.54 M 7.52 M 8.03 M 8.19 M 6.33 M 5.47 M 1.89 M 1.43 M 1.36 M 1.1 M 570 K - - - - - - - - - - - - - - - - - - - - - - - -

General and Administrative Expenses

16.5 M 16.3 M - 20.1 M 5.94 M 4.32 M - 3.92 M 5.17 M 5.12 M - 8 M 7.28 M 6.58 M - 4.65 M 5.11 M 4.99 M 4.02 M 3.49 M 3.59 M 3.54 M 3.27 M 2.86 M 1.96 M 961 K 316 K 238 K 118 K 55 K - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency